Consistent with this idea, our current study shows that compared with healthy controls, the serum HMGB1 levels in some severe COVID-19 patients are significantly increased, indicating that there may be a pathological link between HMGB1 and COVID-19. This evidence concerns the gene HMGB1 and COVID-19.